Gen Z and sexual wellness marketing—4 lessons for legacy brands
In today’s volatile political climate, Gen Zers are increasingly concerned about the future of their sexual rights. Emerging ...
pharmaphorum17h
AZ agrees $1.1bn deal to buy RSV jab developer Icosavax
Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icosavax and its phase 3 ...